ASX SMALL CAPS
articles with this tag
Creso’s New Immunity Boosting CBD Hemp Teas Set for Release
Mar 24, 2020
Creso Pharma Limited (ASX: CPH) is expanding its available product line with the release of a hemp tea in Q3 2020.
ASX MedTech Junior Displays Promise for Pancreatic Cancer Patients
Jan 30, 2020
OncoSil Medical (ASX: OSL) has developed a first-in-class, truly innovative device that treats unresectable locally advanced pancreatic cancer — that is, tumours that can’t be surgically removed.
CPH’s cannaQIX® Products Have Now Exceeded the 2.5 million Lozenges Sold Milestone
Jan 28, 2020
Creso Pharma (ASX:CPH, FRA:1X8) has announced its second major milestone for the year. Today is has informed the market that its flagship cannaQIX® line surpassed the milestone of 100,000 packs sold. The 100,000 pack milestone corresponds to over 2.5 million cannaQIX® lozenges sold since the product’s launch in April 2018.
ANP to Rapidly Advance to Phase IIb Trial After Dosing Results Exceed Expectations
Dec 19, 2019
One ASX biotech that is making progress in DMD therapy and hoping to shake up an industry set to be worth US$4 billion by 2023 is Antisense Therapeutics (ASX:ANP).
ASX Junior Has Early Success With K9 Cancer Trials: Human Trials Await
Nov 7, 2019
One ASX listed clinical stage oncology company is developing novel targeted cancer therapeutics for both humans and animals.
Game Changer? ASX Stock Reverse Engineering Cannabis Plants
Jul 2, 2019
Who is the ASX company with transforming qualities that could completely disrupt the cannabis and CBD markets?
